A biosensor which electrochemically detects a material which relates to a reaction of a specific compound in a liquid sample with a biologically active substance or its related substance, in which the biologically active material or an optionally used mediator is placed at a part which is remote from a position of an electrode which acts as electrochemical detector means, and optionally the biological active material or the mediator is covered with a polymer layer.

Patent
   5382346
Priority
May 17 1991
Filed
Oct 20 1993
Issued
Jan 17 1995
Expiry
May 15 2012
Assg.orig
Entity
Large
444
20
all paid
1. A biosensor which electrochemically detects a material which relates to a reaction of a specific compound in a liquid sample with a biologically active substance, wherein the biologically active material is placed at a part which is remote from a position of an electrode which-acts as electrochemical detector means.
2. The biosensor according to claim 1, which comprises a mediator which is placed at a part which is remote from said position of said electrode together with said biologically active substance.
3. The biosensor according to claim 1, which comprises a mediator which is provided on said electrode.
4. The biosensor according to claim 1, wherein said biologically active substance is bound with a hydrophilic polymer.
5. The biosensor according to claim 3, wherein said mediator is covered with a layer of a hydrophilic polymer.
6. The biosensor according to claim 1, wherein said biologically active substance is an enzyme.
7. The biosensor according to claim 6, wherein said enzyme is an oxidoreductase.

This application is a continuation of copending application Ser. No. 07/883,367, filed on May 15, 1992, now U.S. Pat. No. 5,332,479, the entire contents of which are hereby incorporated by reference.

1. Field of the Invention

The present invention relates to a biosensor and a method of quantitative analysis of a material which relates to a reaction of a specific compound in a liquid sample with a biologically active substance such as an enzyme.

2. Description of the Related Art

When a biological liquid sample such as blood is analyzed using a biosensor which comprises electrochemical detecting means, a reducing compound such as ascorbic acid or uric acid which is present in the sample has an electrochemical or chemical interference on the analysis, which is always a problem in the analysis.

Hitherto, various measures to remove or suppress such interference have been proposed in patent specifications and literatures. They are summarized as follows:

(1) Use of an Interference-removing Membrane

U.S. Pat. Nos. 3,979,274 and 4,240,889, Japanese Patent Kokai Publication Nos. 211542/1982 and 5643/1983, etc.

(2) Electrode Oxidation

U.S. Pat. No. 4,431,507, Japanese Patent Kokai Publication Nos. 118152/1982, 211054/1982, 5642/1983, 85148/1983, 85149/1983 and 146847/1983, The 11th Chemical Sensor Symposium, Okawa et al, 24. "Electrochemical On-Line Elimination of Electroactive Interference for Flow-Type Biosensor System", etc.

(3) Use of Plural Working Electrodes

U.S. Pat. No. 3,539,455, Japanese Patent Kokai Publication Nos. 146847/1983 and 253648/1989, Miyahara et al, Sensor and Actuators, 7, 1 (1985), etc.

(4) Addition of an Enzyme for Oxidizing an Interfering Substances

Japanese Patent Publication No. 17427/1983

(5) Double Potential Step Method

The 58th Spring Annual Meeting of the Japan Chemical Society, 4IG06, Matsuura et al, "Measurement of Hydrogen Peroxide with A Micro Carbon Fiber Electrode".

However, each of the above measures has its own drawbacks as follows:

(1) Use of an Interference-removing Membrane

In this method, an electrode which is an electrochemically detecting device is covered with a selectively permeable membrane, whereby a substance to be analyzed permeates the membrane while concomitant interfering substances do not. This method can be employed when a substance having a very low molecular weight such as oxygen molecules or hydrogen peroxide is used as an electrochemically reactive substance. But, when a mediator for electric charges such as potassium ferricyanide or ferrocene is used, this method cannot be applied since the concomitant interfering substance and the mediator cannot be distinguished according to their sizes. Further, this method cannot be a remedy for an oxidation-reduction reaction between the concomitant substance and the mediator which takes place outside the interference-removing membrane, namely in the sample liquid. In addition, the membrane may decrease a sensitivity and a response of the electrode and a degree of such deterioration depends on a thickness of the membrane so that a difference between individual sensors is enlarged.

(2) Electrode Oxidation

This method requires an additional electrode system for anodizing the concomitant interfering substance in the sample (an electrolytic electrode system) in addition to an electrode system for measuring an object substance (a measuring electrode system). When the sample is supplied to a measuring system, the interfering substance is anodized by the electrolytic electrode system before it reaches an enzyme reaction system or the measuring electrode system.

Since this method essentially requires the electrolytic electrode system in addition to the measuring electrode system, and two electrode systems and the reaction system of the biologically active substance such as an enzyme are spacially separated, the sensor has a complicated structure. To increase an electrolytic efficiency of the interfering substance, a surface area of the electrolytic electrode is increased, or the sample liquid is intentionally stirred or flowed. However, the structure of the sensor is complicated and enlarged, or the response is decreased. This method may not be suitable for a disposable sensor.

The increase of the electrolytic efficiency of the interfering substance is contrary to the reduction of the measuring time and the increase of the response. To satisfy both requirements, a very thin integrated porous electrode system is proposed. But, since such thin electrode is weak and unstable, it requires reinforcement of the structure so that it is difficult to supply a simple and cheap sensor.

Since the sensor as a whole has the electrolytic electrode system in addition to the measuring electrode system, electric circuits and a measuring software become complicated and expensive.

(3) Use of Plural Working Electrodes

In this method, an electrode system for measuring the interfering substance present in the sample is used in addition to the measuring electrode system. When the sample is supplied, the measuring electrode system measures signals from both the object substance and the interfering substance while the electrode system for measuring the interfering substance measures only the signal from the interfering substance. Then, a difference between these two measured value is calculated to give a concentration of the object substance to be measured.

This method essentially requires the electrode system for measuring the interfering substance. Since there is a possibility that a reaction product or reaction products produced by the measuring electrode system may have some influence on the electrode system for measuring the interfering substance, these two electrode systems should be spacially separated with a sufficient distance. This results in enlargement and a more complicated structure of the whole sensor. Since two or more electrode systems are used, two or more electric circuits for amplifying detected currents are necessary.

Further, measuring sensitivities for the object substance measurement and the interfering substance measurement should be matched, but such matching of the sensitivities is very difficult practically. In the case of a repetitive use sensor, the sensitivities of the electrode systems for measuring the interfering substance may be calibrated, but such calibration is impossible for the disposable sensor.

(4) Addition of an Enzyme for Oxidizing an Interfering Substance

In this method, the interfering substance such as ascorbic acid or uric acid is oxidized with a respective oxidase before it participates in the electrode reaction or the oxidation-reduction reaction with the substance to be measured. Since a highly specific enzyme is used to remove the interfering substance in this method, plural enzymes should be used when plural interfering substances are present in the sample. This leads to the increase of a production cost of the biosensor. The preoxidation of the interfering substance is essential, and it is necessary to prevent interference of the measurement of the object substance caused by a product from oxidation of the interfering substance. Therefore, the sensor has a complicated structure inevitably. In addition, the interfering substance is removed through a conversion by the oxidation to a material which cannot be measured. This means that some information, which may be valuable if measured, is discarded.

(5) Double Potential Step Method

When a natural potential (E02) of the measuring electrode against the object substance to be measured and a natural potential (E01) against the interfering substance are different (assuming E01 <E02), the concentration of the interfering substance is measured at a potential E1 which satisfies E01 <E1 <E02, while a total concentration of the object substance and the interfering substance is measured at a potential E2 which is larger than E02 (E02 <E2), and then a difference between E1 and E2 is calculated to obtain the concentration of the object substance.

According to the measuring principle of this method, if the natural potential E02 against the object substance and the natural potential E01 against the interfering substance are not sufficiently different, the concentration of the object substance and the total concentration of the object substance and the interfering substance cannot be separated and measured. When the object substance to be measured is hydrogen peroxide, the above potential relationship can be often established. Depending on an electrode substance or a surface condition of the electrode, E01 and E02 are very close to each other or sometimes E01 exceeds E02.

To achieve stability or expansion of a linear range of the biosensor, the mediator is often used. In such case, the electric charges are transferred with the mediator between the electrode and the object substance to be measured or the interfering substance, E01 and E02 are equal. Therefore, the double potential step method cannot be used.

One object of the present invention is to provide a biosensor which can isolate a signal from an object substance to be measured from a signal from an interfering substance.

Another object of the present invention is to provide a method of quantitative analysis of a material which relates to a reaction of a specific compound in a liquid sample with a biologically active substance such as an enzyme.

According to a first aspect of the present invention, there is provided a biosensor which electrochemically detects a material which relates to a reaction of a specific compound in a liquid sample with a biologically active substance or its related substance (hereinafter referred to as "biologically active material"), wherein the biologically active material or an optionally used mediator is placed at a part which is remote from a position of an electrode which acts as electrochemical detector means, and optionally the biological active material or the mediator is covered with a polymer layer.

According to a second aspect of the present invention, there is provided a method of quantitative analysis of a material which relates to a reaction of a specific compound in a liquid sample with the biologically active material, comprising reading at least two electrochemical signals from the liquid sample, which are an electrochemical signal at the supply of the sample relating to an electrochemically active substance present in the sample but not to a biologically active material and an electrochemical signal after a sufficient time from the supply of the sample relating to both the biologically active material and the electrochemically active substance present in the sample and operating both signals, whereby the substance which specifically reacts with the biologically active material and the electrochemically active material present in the sample are separated and quantitatively analyzed.

FIG. 1 is a schematic cross section of an example of the biosensor according to the present invention,

FIG. 2 is a graph showing anodizing currents measured in Examples 1 and 2,

FIGS. 3, 4 and 5 are graphs showing changes of anodizing currents at lactic acid concentrations of 0 mg/dl, 17.6 mg/dl and 35.2 mg/dl, respectively,

FIG. 6 is a calibration curve of response currents in FIGS. 3, 4 and 5 after 4 seconds from the start of measurement against the concentration of ascorbic acid,

FIG. 7 is a calibration curve of response currents in FIGS. 3, 4 and 5 after 35 seconds from the start of the measurement against the concentration of lactic acid, and

FIG. 8 is a corrected calibration curve obtained by correcting the calibration curve of FIG. 7 with that of FIG. 6.

In the present invention, the biologically active material includes:

1. Substrates of oxidoreductases, for example, lactic acid, glucose, uric acid, piruvic acid, cholesterol, and the like.

2. Oxidoreductases, for example, lactase dehydrogenase, isocitrate dehydrogenase, glutamic dehydrogenase, glucose 6-phosphate dehydrogenase, and the like.

3. Substances which finally perform an oxidation-reduction reaction utilizing a reaction of a substrate or an enzyme, for example, triglyceride, phospholipid, glutamic-oxaloacetic transaminace (GOT), glutamic-pyruvic transaminace (GPT), creatine phosphokinase (CPK), and the like.

4. Substances measured by utilizing an antigen-antibody reaction, for example, immunoglobulins, hormones (e.g. T3, T4, etc.), and the like.

In the present invention, the wording "placing the biologically active material" intends to mean that the biologically active material is present at a specific part of the biosensor in a state that the biologically active material can react with the specific substance to be analyzed in the sample. The wording "placing the mediator" intends to mean that the mediator is present at a specific part of the biosensor in a state that the mediator can be dissolved in the liquid sample. A form of the biologically active material or the mediator is not limited. For example, a solution of the biologically active material is applied on the specific part of the biosensor and dried to place the biologically active material as a residue at the specific part of the biosensor. The solution of the biologically active material is impregnated in an absorbing material such as a filter paper or a piece of cloth and then dried, and the absorbing material carrying the biologically active material is set at the specific part of the biosensor. Further, some of the biologically active materials may be set at the specific part of the biosensor with a cross-linking agent such as glutaraldehyde or disuccinimidyl suberate. The biologically active material may be absorbed on the material of the biosensor substrate using an absorptivity therebetween.

When the biosensor utilizes the mediator, on the measuring electrode, the mediator is placed but no biologically active material is provided. The mediator may be mixed with an hydrophitic polymer and then provided.

The biologically active material is placed together with at least the mediator at the specific part of the biosensor which is sufficiently remote from the measuring electrode. The distance between the measuring electrode and the specific part where the biologically active material is placed is determined such that, in a very short time in which the mediator on the measuring electrode is dissolved in the sample after the sample is supplied and the signal due to the electrode reaction is read (for example, 0 to several seconds, e.g. 5 or 6 seconds), a mediator which is generated by the reaction between the object substance in the sample and the biologically active material does not diffuse and reach the measuring electrode.

In the case of the biosensor using no mediator such as a biosensor using a hydrogen peroxide electrode, preferably any material is not provided on the measuring electrode. To facilitate and smoothen the introduction of the sample, the hydrophilic polymer and the like may be provided on the electrode. The biologically active material is placed at the specific part of the biosensor which is sufficiently remote from the measuring electrode. The distance between the measuring electrode and the specific part where the biologically active material is placed is determined such that, in a very short time in which, after the supply of the sample, the signal generated by the direct electrode reaction of the interfering substance in the sample is read (for example, 0 to several seconds, e.g. 5 or 6 seconds), a material such as hydrogen peroxide which is generated by the reaction between the object substance in the sample and the biologically active material does not diffuse and reach the measuring electrode.

To adjust or prolong the time in which the mediator or the material such as hydrogen peroxide that diffuses from the specific part apart from the measuring electrode reaches the measuring electrode, an amount of the hydrophilic polymer to be combined with a layer of the biologically active material may be increased. Alternatively, the biologically active material layer may be covered with a layer of the hydrophilic polymer.

In the quantitative analysis method of the present invention, when or immediately after the sample is supplied (in general, within several seconds, e.g. 5 or 6 seconds), a first electric current is measured, and then after a sufficient time from the supply of the sample (in general, several ten seconds, e.g. 50 or 60 seconds), a second electric current is measured. A first measured value of the electric current is a current before the produced material of the reaction between the object substance to be measured and the biologically active material reaches the measuring electrode. With this first current, a concentration of the concomitant interfering substance(s) can be determined. A second measured value of the electric current is a current caused by the interfering substance(s) and the produced material of the reaction between the object substance and the biologically active material. With the second current, a total concentration of the concomitant interfering substance(s) and the produced material can be determined. Therefore, a difference between the total concentration determined from the second current and the concentration determined from the first current is a concentration of the object substance to be measured. Timings for measuring the first and second currents should be suitable for measuring the current attributed to the interfering substance(s) and the current attributed to both the interfering substance(s) and the produced material. Therefore, the timings for measuring the currents are not limited to the above exemplified general periods.

The present invention will be explained in detail by following Examples, which do not limit the scope of the present invention.

A schematic cross section of a produced two-electrode type analysis biosensor according to the present invention is shown in FIG. 1.

On a sheet form substrate 1 made of polyethylene terephthalate (PET), a carbon electrode 2 having a silver lead wire is formed by silk screen printing. On the electrode 2, a PET spacer 3 having a space 3' which receives a test liquid is adhered with a double-coated adhesive tape. On the top surface of the spacer 3 (opposite to the electrode 2), a lid 4 is adhered with a double-coated adhesive tape. The test liquid is supplied in the space 3' from an opening 7, whereby the measurement is carried out.

The substance(s) are placed by one of the following methods (A), (B) and (C):

(A) On an area 5 having a specific surface area of the carbon electrode 2, 3.3 mM potassium ferricyanide (30 μl) is dropped and dried to place a solid layer of potassium ferricyanide.

(B) On a surface 6 of the lid 7, before the lid is adhered, 0.1M citrate buffer (5 μl) containing 160 mM potassium ferricyanide and 400 U/ml of lactate oxidase was dropped and dried to place a solid layer of the enzyme and potassium ferricyanide.

(C) On an area 5 having a specific surface area of the carbon electrode 2, 3.3 mM potassium ferricyanide (30 μl) is dropped and dried to place a solid layer of potassium ferricyanide. Also, on a surface 6 of the lid 7, before the lid is adhered, 0.1M citrate buffer (5 μl) containing 160 mM potassium ferricyanide and 400 U/ml of lactate oxidase was dropped and dried to place a solid layer of the enzyme and potassium ferricyanide.

From the opening 7 of the sensor produced by the method (A) in Example 1, 2 mM aqueous solution of ascorbic acid (10 μl) was introduced. Simultaneously, a constant voltage of +200 mV was applied between a detection electrode and a counter electrode and an anodizing current was measured. The result is shown in FIG. 2 (line A). The anode current reached the maximum value after 0.5 second by the application of +200 mV. This means that the reduction reaction of potassium ferricyanide with ascorbic acid is very fast and the current generated by this reaction is detected quickly.

In the same manner as in Example 2 but using the sensor produced by the method (B) in Example 1 and 5 mM aqueous solution of lactic acid (10 μl), the change of the anodizing current was measured. The result is shown in FIG. 2 (line B). The anode current was substantially 0 μA after 4 seconds from the start of the application of +200 mV. This means that the arrival of potassium ferricyanide generated by the enzymatic reaction of lactic acid at the position 6 of FIG. 1 was delayed by about 4 seconds.

An aqueous solution was prepared by adding ascorbic acid at a concentration of 0 mg/dl, 17.6 mg/dl or 35.2 mg/dl (each an end concentration) to a solution of lactic acid of a concentration of 0 mg/dl, 9.0 mg/dl, 18.0 mg/dl or 45.0 mg/dl. Then, 10 μl of each of the solutions was introduced in the sensor produced by the method (C) from the opening 7. Simultaneously, a first voltage of +200 mV was applied for 4 seconds between a detection electrode and a counter electrode and an anodizing current was measured. After 30 seconds from the introduction of the test solution, a second voltage of +200 mV was applied for 5 seconds, during which the anodizing current was measured. The result is shown in FIGS. 3 to 5, which show the changes of the anode current with time using the solutions containing 0 mg/dl (FIG. 3), 17.6 mg/dl (FIG. 4) or 35.2 mg/dl (FIG. 5) of ascorbic acid and 9.0 mg/dl, 18.0 mg/dl or 45.0 mg/dl of lactic acid.

FIG. 6 shows a calibration curve, in which the response currents (anode currents) in FIGS. 3 to 5 after 4 seconds from the introduction of the test solution were on the ordinate and the concentrations of ascorbic acid were on the abscissa. Though the lactic acid concentrations varied widely, the calibration curves for the three different lactic acid concentrations could be approximated by one calibration curve.

FIG. 7 shows calibration curves, in which the response currents (anode currents) in FIGS. 3 to 5 after 35 seconds from the introduction of the test solution were on the ordinate and the concentrations of lactic acid were on the abscissa. The calibration curves shifted in the positive direction of the ordinate with the response current corresponding to the respective concentration of ascorbic acid. This means that ascorbic acid has a positive interference against the measurement of lactic acid.

The calibration curves of FIG. 7 were corrected using the calibration curve of FIG. 6. That is, by taking into consideration the sensitivity difference of the response current between the time of the first voltage application and the time of the second voltage application, the calibration curve of FIG. 6 was corrected so that each of the calibration curves of FIG. 7 corresponding to the ascorbic acid concentration of 0 mg/dl and 35.2 mg/dl passed the origin, and then, using the corrected calibration curve, all the measured values in FIG. 7 were corrected. The results are shown in FIG. 8. In spite of the large difference of the ascorbic acid concentrations, all the calibration curves could be approximated by a single calibration curve. This means that the concentration of lactic acid is separated from that of ascorbic acid. Namely, the interference of ascorbic acid is avoided from the measurement.

Uenoyama, Harumi, Okuda, Hisashi

Patent Priority Assignee Title
10034628, Dec 12 2005 Sanofi-Aventis Deutschland GmbH Low pain penetrating member
10039881, Dec 31 2002 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
10117614, Feb 08 2006 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
10178954, May 08 2007 Abbott Diabetes Care Inc. Analyte monitoring system and methods
10201301, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
10231654, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
10349874, Sep 29 2009 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
10429250, Aug 31 2009 Abbott Diabetes Care Inc Analyte monitoring system and methods for managing power and noise
10478108, Apr 19 2007 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
10631768, Feb 26 2009 Abbott Diabetes Inc. Self-powered analyte sensor
10653317, May 08 2007 Abbott Diabetes Care Inc. Analyte monitoring system and methods
10750952, Dec 31 2002 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
10952611, May 08 2007 Abbott Diabetes Care Inc. Analyte monitoring system and methods
10952652, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
11045147, Aug 31 2009 Abbott Diabetes Care Inc. Analyte signal processing device and methods
11103165, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
11150145, Aug 31 2009 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
11272867, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
11363975, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
11399748, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
11471075, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
11538580, Nov 04 2005 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
11612363, Sep 17 2012 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
11635332, Aug 31 2009 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
11696684, May 08 2007 Abbott Diabetes Care Inc. Analyte monitoring system and methods
11793936, May 29 2009 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
11872370, May 29 2009 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
11911151, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
5628890, Sep 27 1995 MEDISENSE, INC Electrochemical sensor
5863400, Apr 14 1994 Lifescan, Inc Electrochemical cells
5942102, Nov 15 1996 Lifescan, Inc Electrochemical method
5980709, Apr 12 1995 Lifescan, Inc Method of defining an electrode area
6117289, Dec 20 1996 PHC HOLDINGS CO , LTD ; PANASONIC HEALTHCARE HOLDINGS CO , LTD Cholesterol sensor and method for producing the same
6179979, Nov 16 1995 Lifescan, Inc Electrochemical cell
6251260, Aug 24 1998 Abbott Diabetes Care Inc Potentiometric sensors for analytic determination
6258229, Jun 02 1999 Nova Biomedical Corporation Disposable sub-microliter volume sensor and method of making
6284125, Jun 19 1995 Lifescan, Inc Electrochemical cell
6287451, Jun 02 1999 Nova Biomedical Corporation Disposable sensor and method of making
6299757, Oct 08 1998 Abbott Diabetes Care Inc Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
6325917, Aug 13 1997 Lifescan, Inc Method and apparatus for automatic analysis
6338790, Oct 08 1998 ABBOTT DIABETES CARE, INC Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
6379513, Mar 21 1997 Cilag GmbH International; Lifescan IP Holdings, LLC Sensor connection means
6413410, Jun 19 1996 Lifescan, Inc Electrochemical cell
6444115, Jul 14 2000 Cilag GmbH International; Lifescan IP Holdings, LLC Electrochemical method for measuring chemical reaction rates
6454921, Mar 25 1998 Lifescan, Inc Electrochemical cell
6461496, Oct 08 1998 Abbott Diabetes Care Inc Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
6471839, May 20 1999 Matsushita Electric Industrial Co., Ltd. Biosensor
6475360, Mar 12 1998 Lifescan, Inc Heated electrochemical cell
6521110, Nov 16 1995 Lifescan, Inc Electrochemical cell
6571651, Mar 27 2000 Lifescan, Inc Method of preventing short sampling of a capillary or wicking fill device
6591125, Jun 27 2000 Abbott Diabetes Care Inc Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
6592744, Mar 25 1997 Lifescan, Inc Method of filling an amperometric cell
6592745, Oct 08 1998 Abbott Diabetes Care Inc Method of using a small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
6600057, Dec 29 2000 CITIBANK, N A Matrix metalloproteinase inhibitors
6612111, Mar 27 2000 Lifescan, Inc Method and device for sampling and analyzing interstitial fluid and whole blood samples
6616819, Nov 04 1999 Abbott Diabetes Care Inc Small volume in vitro analyte sensor and methods
6618934, Oct 08 1998 Abbott Diabetes Care Inc Method of manufacturing small volume in vitro analyte sensor
6632349, Nov 15 1996 Lifescan, Inc Hemoglobin sensor
6638415, Nov 16 1995 Lifescan, Inc Antioxidant sensor
6652734, Mar 16 1999 Lifescan, Inc Sensor with improved shelf life
6654625, Jun 18 1999 Abbott Diabetes Care Inc Mass transport limited in vivo analyte sensor
6662439, Oct 04 1999 Roche Diabetes Care, Inc Laser defined features for patterned laminates and electrodes
6749740, Nov 04 1999 Abbott Diabetes Care Inc Small volume in vitro analyte sensor and methods
6767441, Jul 31 2001 Nova Biomedical Corporation Biosensor with peroxidase enzyme
6823750, Mar 27 2000 LifeScan, Inc. Method of preventing short sampling of a capillary or wicking fill device
6837976, Apr 19 2002 Nova Biomedical Corporation Disposable sensor with enhanced sample port inlet
6852212, Aug 13 1997 Lifescan, Inc Method and apparatus for automatic analysis
6863801, Nov 16 1995 Cilag GmbH International; Lifescan IP Holdings, LLC Electrochemical cell
6878251, Mar 12 1998 LifeScan, Inc. Heated electrochemical cell
6911621, Nov 01 2000 Roche Diabetes Care, Inc Biosensor
6939312, Mar 27 2000 LifeScan, Inc. Method and device for sampling and analyzing interstitial fluid and whole blood samples
6942518, Nov 04 1999 Abbott Diabetes Care Inc Small volume in vitro analyte sensor and methods
6942770, Apr 19 2002 Nova Biomedical Corporation Disposable sub-microliter volume biosensor with enhanced sample inlet
6960289, Jun 19 1996 Lifescan, Inc Electrochemical cell
6975893, Jun 18 1999 Abbott Diabetes Care Inc Mass transport limited in vivo analyte sensor
7022217, Jul 14 2000 Cilag GmbH International; Lifescan IP Holdings, LLC Electrochemical method for measuring chemical reaction rates
7025774, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Tissue penetration device
7041068, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Sampling module device and method
7041210, Mar 25 1997 LifeScan, Inc. Method of filling an amperometric cell
7041468, Apr 02 2001 Abbott Diabetes Care Inc Blood glucose tracking apparatus and methods
7041787, Dec 29 2000 CITIBANK, N A Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases
7043821, Mar 27 2000 LifeScan, Inc. Method of preventing short sampling of a capillary or wicking fill device
7045046, Mar 21 1997 Cilag GmbH International; Lifescan IP Holdings, LLC Sensor connection means
7058437, Jun 27 2000 Abbott Diabetes Care Inc Methods of determining concentration of glucose
7073246, Oct 04 1999 Roche Diabetes Care, Inc Method of making a biosensor
7131342, Mar 27 2000 LifeScan, Inc. Method of preventing short sampling of a capillary or wicking fill device
7175897, Nov 12 2003 Avery Dennison Corporation Adhesive articles which contain at least one hydrophilic or hydrophobic layer, method for making and uses for same
7198606, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for a multi-use body fluid sampling device with analyte sensing
7225535, Oct 08 1998 Abbott Diabetes Care Inc Method of manufacturing electrochemical sensors
7226461, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
7229458, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7232451, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7244265, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7258693, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Device and method for variable speed lancet
7287318, Nov 07 2003 Roche Diabetes Care, Inc Biosensor
7291117, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7297122, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7297151, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for body fluid sampling with improved sensing
7316700, Jun 12 2002 Sanofi-Aventis Deutschland GmbH Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
7331931, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7335292, Mar 20 1998 LifeScan, Inc. Sensor with improved shelf life
7344507, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for lancet actuation
7344894, Oct 16 2001 Sanofi-Aventis Deutschland GmbH Thermal regulation of fluidic samples within a diagnostic cartridge
7371247, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7374544, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7386937, Oct 04 1999 Roche Diabetes Care, Inc Method of making a biosensor
7410468, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7431814, Nov 16 1995 Cilag GmbH International; Lifescan IP Holdings, LLC Electrochemical cell
7431820, Oct 10 2001 Cilag GmbH International; Lifescan IP Holdings, LLC Electrochemical cell
7476827, Aug 29 2001 Roche Diabetes Care, Inc Method of making a biosensor
7485128, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7491178, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7524293, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7537571, Jun 12 2002 Sanofi-Aventis Deutschland GmbH Integrated blood sampling analysis system with multi-use sampling module
7547287, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7550069, Oct 08 1998 Abbott Diabetes Care Inc Small volume in vitro analyte sensor
7563232, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7563350, Oct 08 1998 Abbott Diabetes Care Inc Small volume in vitro analyte sensor
7582099, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7587287, Apr 04 2003 Abbott Diabetes Care Inc Method and system for transferring analyte test data
7604592, Jun 14 2004 Sanofi-Aventis Deutschland GmbH Method and apparatus for a point of care device
7604722, Jun 19 1995 Cilag GmbH International; Lifescan IP Holdings, LLC Electrochemical cell
7608175, Jun 19 1995 LifeScan, Inc. Electrochemical cell
7620438, Mar 31 2006 ABBOTT DIABETES CARE, INC Method and system for powering an electronic device
7648468, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7666149, Dec 04 1997 Sanofi-Aventis Deutschland GmbH Cassette of lancet cartridges for sampling blood
7674232, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7682318, Jun 12 2002 Sanofi-Aventis Deutschland GmbH Blood sampling apparatus and method
7699791, Jun 12 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for improving success rate of blood yield from a fingerstick
7708701, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for a multi-use body fluid sampling device
7713214, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing
7717863, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7731729, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7749174, Jun 12 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge
7766829, Nov 04 2005 ABBOTT DIABETES CARE, INC Method and system for providing basal profile modification in analyte monitoring and management systems
7780631, Mar 30 1998 Sanofi-Aventis Deutschland GmbH Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
7780827, Aug 29 2001 Roche Diabetes Care, Inc Biosensor
7807043, Feb 23 2004 LEADWAY HK LTD Microfluidic test device
7811231, Dec 31 2002 Abbott Diabetes Care Inc Continuous glucose monitoring system and methods of use
7822454, Jan 03 2005 Sanofi-Aventis Deutschland GmbH Fluid sampling device with improved analyte detecting member configuration
7833171, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7850621, Jun 07 2004 Sanofi-Aventis Deutschland GmbH Method and apparatus for body fluid sampling and analyte sensing
7850622, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
7860544, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
7862520, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Body fluid sampling module with a continuous compression tissue interface surface
7869853, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
7874994, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7875047, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
7885699, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
7892183, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for body fluid sampling and analyte sensing
7892185, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for body fluid sampling and analyte sensing
7892849, Jun 20 2003 Roche Diabetes Care, Inc Reagent stripe for test strip
7901362, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7901365, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7906009, Feb 06 1997 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
7909775, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
7909777, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7909778, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7909984, Feb 06 1997 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
7914465, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7920907, Jun 07 2006 ABBOTT DIABETES CARE, INC Analyte monitoring system and method
7928850, May 08 2007 ABBOTT DIABETES CARE, INC Analyte monitoring system and methods
7938787, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7976476, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Device and method for variable speed lancet
7976778, Apr 02 2001 Abbott Diabetes Care Inc Blood glucose tracking apparatus
7981055, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
7981056, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Methods and apparatus for lancet actuation
7988644, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
7988645, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
7988845, Feb 06 1997 Abbott Diabetes Care Inc. Integrated lancing and measurement device and analyte measuring methods
8007446, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8016774, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8062231, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8066639, Jun 10 2003 Abbott Diabetes Care Inc Glucose measuring device for use in personal area network
8066858, Nov 04 1999 Abbott Diabetes Care Inc. Analyte sensor with insertion monitor, and methods
8075760, Jun 19 1995 Lifescan, Inc Electrochemical cell
8079960, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Methods and apparatus for lancet actuation
8083924, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
8083928, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
8083929, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro sensor and methods of making
8087162, Oct 08 1998 Abbott Diabetes Care Inc. Methods of making small volume in vitro analyte sensors
8091220, Oct 08 1998 Abbott Diabetes Care Inc. Methods of making small volume in vitro analyte sensors
8101056, Jun 19 1995 LIFESCAN INC Electrochemical cell
8103456, Jan 29 2009 ABBOTT DIABETES CARE, INC Method and device for early signal attenuation detection using blood glucose measurements
8105476, Feb 06 1997 Abbott Diabetes Care Inc. Integrated lancing and measurement device
8112240, Apr 29 2005 Abbott Diabetes Care Inc Method and apparatus for providing leak detection in data monitoring and management systems
8114270, Feb 06 1997 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
8114271, Feb 06 1997 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
8118992, Feb 06 1997 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
8118993, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
8123686, Mar 01 2007 ABBOTT DIABETES CARE, INC Method and apparatus for providing rolling data in communication systems
8123700, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
8123929, Feb 06 1997 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
8142642, Feb 06 1997 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
8142643, Feb 06 1997 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
8149117, May 08 2007 Abbott Diabetes Care Inc Analyte monitoring system and methods
8153063, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
8157748, Apr 16 2002 Sanofi-Aventis Deutschland GmbH Methods and apparatus for lancet actuation
8162829, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8162830, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8163164, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
8175673, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8177716, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8182670, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
8182671, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
8186044, Oct 08 1998 Abbott Diabetes Care Inc. Method of manufacturing small volume in vitro analyte sensors
8187183, Dec 31 2002 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
8187895, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
8192611, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
8197421, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8197423, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8202231, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8206317, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8206319, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8211037, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8211363, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
8216154, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8221334, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8221685, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro sensor and methods of making
8224413, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8226555, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8226557, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8226558, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8226815, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro sensor and methods of making
8226891, Mar 31 2006 ABBOTT DIABETES CARE, INC Analyte monitoring devices and methods therefor
8231532, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8235896, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8235915, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8236242, Apr 02 2001 Abbott Diabetes Care Inc. Blood glucose tracking apparatus and methods
8251921, Jun 06 2003 Sanofi-Aventis Deutschland GmbH Method and apparatus for body fluid sampling and analyte sensing
8255031, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8260392, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8262614, Jun 01 2004 Sanofi-Aventis Deutschland GmbH Method and apparatus for fluid injection
8262996, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro sensor and methods of making
8265726, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8267870, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for body fluid sampling with hybrid actuation
8268144, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
8268163, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
8268243, Apr 02 2001 Abbott Diabetes Care Inc. Blood glucose tracking apparatus and methods
8272125, Oct 08 1998 Abbott Diabetes Care Inc. Method of manufacturing in vitro analyte sensors
8273022, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8273241, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
8275439, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8282576, Sep 29 2004 Sanofi-Aventis Deutschland GmbH Method and apparatus for an improved sample capture device
8282577, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
8287454, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8287703, Oct 04 1999 Roche Diabetes Care, Inc Biosensor and method of making
8296918, Dec 31 2003 Sanofi-Aventis Deutschland GmbH Method of manufacturing a fluid sampling device with improved analyte detecting member configuration
8306598, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8337421, Oct 04 2005 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8346336, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8346337, Nov 05 2007 Abbott Diabetes Care Inc Analyte monitoring device and methods of use
8353829, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8357091, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8360991, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8360992, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8362904, May 08 2007 Abbott Diabetes Care Inc. Analyte monitoring system and methods
8366614, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8366637, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8372005, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8372016, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for body fluid sampling and analyte sensing
8372261, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
8377378, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
8380273, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8382682, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8382683, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8388551, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for multi-use body fluid sampling device with sterility barrier release
8391945, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8403864, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8409131, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8414503, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Methods and apparatus for lancet actuation
8425743, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
8425758, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
8430828, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
8435190, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8437966, Apr 04 2003 Abbott Diabetes Care Inc Method and system for transferring analyte test data
8439872, Mar 30 1998 Sanofi-Aventis Deutschland GmbH Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
8449740, Mar 31 2006 Cilag GmbH International; Lifescan IP Holdings, LLC Systems and methods for discriminating control solution from a physiological sample
8449758, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
8456301, May 08 2007 ABBOTT DIABETES CARE, INC Analyte monitoring system and methods
8461985, May 08 2007 ABBOTT DIABETES CARE, INC Analyte monitoring system and methods
8465425, Nov 01 2005 Abbott Diabetes Care Inc Analyte monitoring device and methods of use
8473021, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8473220, Jan 29 2009 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
8480580, Apr 30 1998 ABBOTT DIABETES CARE, INC Analyte monitoring device and methods of use
8483974, Apr 04 2003 Abbott Diabetes Care Inc Method and system for transferring analyte test data
8486243, Oct 10 2001 Cilag GmbH International; Lifescan IP Holdings, LLC Electrochemical cell
8486649, Jan 17 2008 LifeScan, Inc. System and method for measuring an analyte in a sample
8491500, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Methods and apparatus for lancet actuation
8496601, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Methods and apparatus for lancet actuation
8512239, Jun 10 2003 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
8529751, Mar 31 2006 Cilag GmbH International; Lifescan IP Holdings, LLC Systems and methods for discriminating control solution from a physiological sample
8532731, Jun 27 2000 Abbott Diabetes Care Inc. Methods of determining analyte concentration
8551308, Oct 04 1999 Roche Diabetes Care, Inc Biosensor and method of making
8551320, Jun 09 2008 Cilag GmbH International; Lifescan IP Holdings, LLC System and method for measuring an analyte in a sample
8556829, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8560250, Apr 04 2003 Abbott Diabetes Care Inc Method and system for transferring analyte test data
8562545, Oct 04 2005 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8574895, Dec 30 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus using optical techniques to measure analyte levels
8579831, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8585591, Nov 04 2005 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
8593109, Mar 31 2006 Abbott Diabetes Care Inc. Method and system for powering an electronic device
8593287, May 08 2007 Abbott Diabetes Care Inc. Analyte monitoring system and methods
8597189, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8597480, Jun 19 1995 LifeScan, Inc. Electrochemical cell
8597575, Mar 31 2006 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
8603768, Jan 17 2008 Cilag GmbH International; Lifescan IP Holdings, LLC System and method for measuring an analyte in a sample
8612159, Apr 30 1998 Abbott Diabetes Care Inc Analyte monitoring device and methods of use
8617071, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8622903, Dec 31 2002 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
8622906, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8622930, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8636673, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8641619, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8641643, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Sampling module device and method
8641644, Nov 21 2000 Sanofi-Aventis Deutschland GmbH Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
8647269, Jun 10 2003 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
8649841, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8650751, Oct 08 1998 Abbott Diabetes Care Inc. Methods of making small volume in vitro analyte sensors
8652043, Jan 02 2001 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8652831, Dec 30 2004 Sanofi-Aventis Deutschland GmbH Method and apparatus for analyte measurement test time
8660627, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8665091, May 08 2007 Abbott Diabetes Care Inc.; Abbott Diabetes Care Inc Method and device for determining elapsed sensor life
8666469, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8668645, Jan 02 2001 Abbott Diabetes Care Inc Analyte monitoring device and methods of use
8668656, Dec 31 2003 Sanofi-Aventis Deutschland GmbH Method and apparatus for improving fluidic flow and sample capture
8670815, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8672844, Apr 30 1998 Abbott Diabetes Care Inc Analyte monitoring device and methods of use
8676513, Jan 29 2009 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
8679033, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8682598, Apr 04 2003 Abbott Diabetes Care Inc Method and system for transferring analyte test data
8685714, Jul 14 2000 Universal Biosensors Pty Ltd Immunosensor
8688188, Nov 01 2005 Abbott Diabetes Care Inc Analyte monitoring device and methods of use
8690796, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8701282, Oct 08 1998 Abbott Diabetes Care Inc. Method for manufacturing a biosensor
8702624, Sep 29 2006 Sanofi-Aventis Deutschland GmbH Analyte measurement device with a single shot actuator
8709739, Jan 17 2008 Cilag GmbH International; Lifescan IP Holdings, LLC System and method for measuring an analyte in a sample
8721671, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Electric lancet actuator
8728297, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
8732188, Feb 18 2007 ABBOTT DIABETES CARE, INC Method and system for providing contextual based medication dosage determination
8734346, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8734348, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8738109, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8744545, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8765059, Apr 02 2001 Abbott Diabetes Care Inc. Blood glucose tracking apparatus
8771183, Dec 31 2002 Abbott Diabetes Care Inc Method and system for providing data communication in continuous glucose monitoring and management system
8774887, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8778168, Sep 28 2007 Cilag GmbH International; Lifescan IP Holdings, LLC Systems and methods of discriminating control solution from a physiological sample
8784335, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Body fluid sampling device with a capacitive sensor
8795176, Jun 27 2000 Abbott Diabetes Care Inc. Integrated sample acquisition and analyte measurement device
8801907, Oct 10 2001 Cilag GmbH International; Lifescan IP Holdings, LLC Electrochemical cell
8808201, Apr 19 2002 SANOFI S A ; Sanofi-Aventis Deutschland GmbH Methods and apparatus for penetrating tissue
8808531, Feb 06 1997 Abbott Diabetes Care Inc Small volume in vitro analyte sensor
8828203, May 20 2005 SANOFI S A Printable hydrogels for biosensors
8840553, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8845549, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method for penetrating tissue
8845550, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8871068, Jul 19 2007 Roche Diabetes Care, Inc Continuous monitor sensor with covalently bound enzyme
8880137, Apr 30 1998 Abbott Diabetes Care Inc Analyte monitoring device and methods of use
8905945, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8915850, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8916040, Jan 17 2008 Cilag GmbH International; Lifescan IP Holdings, LLC System and method for measuring an analyte in a sample
8920319, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8930203, Feb 18 2007 Abbott Diabetes Care Inc Multi-function analyte test device and methods therefor
8933664, Mar 31 2006 Abbott Diabetes Care Inc. Method and system for powering an electronic device
8945910, Sep 29 2003 Sanofi-Aventis Deutschland GmbH Method and apparatus for an improved sample capture device
8965476, Apr 16 2010 Pelikan Technologies, Inc Tissue penetration device
8974386, Apr 30 1998 ABBOTT DIABETES CARE, INC Analyte monitoring device and methods of use
8993331, Aug 31 2009 Abbott Diabetes Care Inc Analyte monitoring system and methods for managing power and noise
9000929, May 08 2007 Abbott Diabetes Care Inc. Analyte monitoring system and methods
9011331, Apr 30 1998 Abbott Diabetes Care Inc Analyte monitoring device and methods of use
9011332, Jan 02 2001 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
9014773, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
9017259, Jun 27 2000 Abbott Diabetes Care Inc. Integrated sample acquisition and analyte measurement device
9020573, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
9034639, Dec 30 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus using optical techniques to measure analyte levels
9035767, May 08 2007 Abbott Diabetes Care Inc. Analyte monitoring system and methods
9039975, Mar 31 2006 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
9042953, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
9066694, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
9066695, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
9066697, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
9066709, Jan 29 2009 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
9072477, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
9075004, Jun 19 1996 LifeScan, Inc. Electrochemical cell
9078607, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
9089678, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
9095290, Mar 01 2007 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
9144401, Dec 12 2005 Sanofi-Aventis Deutschland GmbH Low pain penetrating member
9157110, Sep 28 2007 Cilag GmbH International; Lifescan IP Holdings, LLC Systems and methods of discriminating control solution from a physiological sample
9177456, May 08 2007 Abbott Diabetes Care Inc. Analyte monitoring system and methods
9226699, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Body fluid sampling module with a continuous compression tissue interface surface
9226701, Apr 28 2009 Abbott Diabetes Care Inc Error detection in critical repeating data in a wireless sensor system
9234863, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
9234864, Feb 06 1997 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
9271669, Jun 27 2000 Abbott Diabetes Care Inc. Method for integrated sample acquisition and analyte measurement device
9274078, Mar 31 2006 Cilag GmbH International; Lifescan IP Holdings, LLC Systems and methods of discriminating control solution from a physiological sample
9291592, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
9314194, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Tissue penetration device
9314195, Aug 31 2009 Abbott Diabetes Care Inc Analyte signal processing device and methods
9314198, May 08 2007 Abbott Diabetes Care Inc. Analyte monitoring system and methods
9316609, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
9320461, Sep 29 2009 Abbott Diabetes Care Inc Method and apparatus for providing notification function in analyte monitoring systems
9323898, Nov 04 2005 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
9326714, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
9326716, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
9339612, Oct 04 2005 Sanofi-Aventis Deutschland GmbH Tissue penetration device
9341591, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
9351680, Oct 14 2003 Sanofi-Aventis Deutschland GmbH Method and apparatus for a variable user interface
9375169, Jan 30 2009 Sanofi-Aventis Deutschland GmbH Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
9380971, Mar 31 2006 Abbott Diabetes Care Inc. Method and system for powering an electronic device
9386944, Apr 11 2008 Sanofi-Aventis Deutschland GmbH Method and apparatus for analyte detecting device
9477811, Apr 02 2001 Abbott Diabetes Care Inc Blood glucose tracking apparatus and methods
9498159, Jan 02 2001 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
9574914, May 08 2007 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
9610034, Jan 02 2001 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
9625413, Mar 31 2006 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
9649057, May 08 2007 Abbott Diabetes Care Inc. Analyte monitoring system and methods
9662057, Jun 27 2000 Abbott Diabetes Care Inc. Integrated sample acquisition and analyte measurement method
9668684, Feb 26 2009 Abbott Diabetes Care Inc. Self-powered analyte sensor
9669162, Nov 04 2005 ABBOTT DIABETES CARE, INC Method and system for providing basal profile modification in analyte monitoring and management systems
9730584, Jun 10 2003 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
9739745, Jun 09 2008 LifeScan, Inc. System and method for measuring an analyte in a sample
9739749, Jan 17 2008 Cilag GmbH International; Lifescan IP Holdings, LLC System and method for measuring an analyte in a sample
9743863, Mar 31 2006 Abbott Diabetes Care Inc. Method and system for powering an electronic device
9750439, Sep 29 2009 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
9775553, Jun 03 2004 Sanofi-Aventis Deutschland GmbH Method and apparatus for a fluid sampling device
9784707, Jun 09 2008 Cilag GmbH International; Lifescan IP Holdings, LLC System and method for measuring an analyte in a sample
9795334, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
9795747, Jun 02 2010 Pelikan Technologies, Inc Methods and apparatus for lancet actuation
9801545, Mar 01 2007 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
9820684, Jun 03 2004 Sanofi-Aventis Deutschland GmbH Method and apparatus for a fluid sampling device
9863942, Mar 21 2002 Universal Biosensors Pty Ltd Biosensor apparatus and methods of use
9891185, Oct 08 1998 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
9907502, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
9937298, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
9949678, May 08 2007 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
9962091, Dec 31 2002 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
9968302, Aug 31 2009 Abbott Diabetes Care Inc. Analyte signal processing device and methods
9968306, Sep 17 2012 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
9980669, Nov 07 2011 Abbott Diabetes Care Inc Analyte monitoring device and methods
RE41264, Jul 31 2001 Nova Biomedical Corporation Biosensor with peroxidase enzyme
RE42567, Nov 16 1995 Cilag GmbH International; Lifescan IP Holdings, LLC Electrochemical cell
RE44330, Jun 19 1995 LifeScan Inc. Electrochemical cell
Patent Priority Assignee Title
3539455,
3707455,
3979274, Sep 24 1975 The Yellow Springs Instrument Company, Inc. Membrane for enzyme electrodes
4240889, Jan 28 1978 Toyo Boseki Kabushiki Kaisha Enzyme electrode provided with immobilized enzyme membrane
4340448, Aug 28 1978 University of Pittsburgh Potentiometric detection of hydrogen peroxide and apparatus therefor
4431507, Jan 14 1981 Matsushita Electric Industrial Co., Ltd. Enzyme electrode
5120420, Mar 31 1988 MATSUSHITA ELECTRIC INDUSTRIAL CO , LTD Biosensor and a process for preparation thereof
EP304947,
EP359831,
FR2643150,
JP1253648,
JP57118152,
JP57211054,
JP57211542,
JP58146847,
JP5817427,
JP585642,
JP585643,
JP5885148,
JP5885149,
/
Executed onAssignorAssigneeConveyanceFrameReelDoc
Oct 20 1993Kyoto Daiichi Kagaku Co., Ltd.(assignment on the face of the patent)
Date Maintenance Fee Events
Jun 24 1998M183: Payment of Maintenance Fee, 4th Year, Large Entity.
Jun 24 1999ASPN: Payor Number Assigned.
Jun 20 2002M184: Payment of Maintenance Fee, 8th Year, Large Entity.
Feb 22 2006ASPN: Payor Number Assigned.
Feb 22 2006RMPN: Payer Number De-assigned.
Jul 13 2006M1553: Payment of Maintenance Fee, 12th Year, Large Entity.


Date Maintenance Schedule
Jan 17 19984 years fee payment window open
Jul 17 19986 months grace period start (w surcharge)
Jan 17 1999patent expiry (for year 4)
Jan 17 20012 years to revive unintentionally abandoned end. (for year 4)
Jan 17 20028 years fee payment window open
Jul 17 20026 months grace period start (w surcharge)
Jan 17 2003patent expiry (for year 8)
Jan 17 20052 years to revive unintentionally abandoned end. (for year 8)
Jan 17 200612 years fee payment window open
Jul 17 20066 months grace period start (w surcharge)
Jan 17 2007patent expiry (for year 12)
Jan 17 20092 years to revive unintentionally abandoned end. (for year 12)